Literature DB >> 9760689

Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase.

S V Frye1, H N Bramson, D J Hermann, F W Lee, A K Sinhababu, G Tian.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9760689     DOI： 10.1007/0-306-47384-4_17

Source DB:  PubMed          Journal:  Pharm Biotechnol        ISSN： 1078-0467


× No keyword cloud information.
  8 in total

1.  Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds.

Authors:  D J Burinsky; J D Williams; A D Thornquest; S L Sides
Journal:  J Am Soc Mass Spectrom       Date:  2001-04       Impact factor: 3.109

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 3.  Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

Authors:  Silvia Giatti; Silvia Diviccaro; Giancarlo Panzica; Roberto Cosimo Melcangi
Journal:  Endocrine       Date:  2018-04-19       Impact factor: 3.633

Review 4.  Dutasteride.

Authors:  Hannah C Evans; Karen L Goa
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.

Authors:  Michael G Zager; Hugh A Barton
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

6.  Post-finasteride syndrome: An emerging clinical problem.

Authors:  Silvia Diviccaro; Roberto Cosimo Melcangi; Silvia Giatti
Journal:  Neurobiol Stress       Date:  2019-12-26

7.  Testosterone reduces knee passive range of motion and expression of relaxin receptor isoforms via 5α-dihydrotestosterone and androgen receptor binding.

Authors:  Firouzeh Dehghan; Sekaran Muniandy; Ashril Yusof; Naguib Salleh
Journal:  Int J Mol Sci       Date:  2014-03-17       Impact factor: 5.923

Review 8.  The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.

Authors:  Eric H Kim; John A Brockman; Gerald L Andriole
Journal:  Asian J Urol       Date:  2017-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.